# DC Funds, LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1869028. Source: https://holderbook.com/funds/1869028-dc-funds-lp/

- Reported value: $1.3B
- Positions: 3
- Weight of the ten largest: 100.0%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| TSCAN THERAPEUTICS INC | [TCRX](https://holderbook.com/stocks/TCRX/) | $617.5M | 630,000 | 49.3% | 20 |
| BARINTHUS BIOTHERAPEUTICS PL | [BRNS](https://holderbook.com/stocks/BRNS/) | $423.9M | 642,204 | 33.8% | 21 |
| WEREWOLF THERAPEUTICS INC | [HOWL](https://holderbook.com/stocks/HOWL/) | $212.0M | 589,102 | 16.9% | 21 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $1.3B | 3 |
| Q1 2026 | $1.5B | 3 |
| Q4 2025 | $1.5B | 3 |
| Q3 2025 | $3.1B | 3 |
| Q2 2025 | $2.2B | 3 |
| Q1 2025 | $2.1B | 3 |
| Q4 2024 | $3.6B | 3 |
| Q3 2024 | $5.2B | 3 |
| Q2 2024 | $6.0B | 3 |
| Q1 2024 | $10.3M | 3 |
| Q4 2023 | $8.3M | 3 |
| Q3 2023 | $4.9B | 3 |